Navigation Links
Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
Date:9/9/2009

SAN DIEGO, Sept. 9 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.

"ANA598 has demonstrated potent antiviral activity and good tolerability as a single agent, as well as preclinical properties indicative of likely synergy when used clinically in combination regimens," said James Freddo, M.D., Anadys' Senior Vice President, Drug Development and Chief Medical Officer. "We look forward to building upon these results to demonstrate the benefit of ANA598 when used in combination with interferon and ribavirin."

About the Phase II Study

In the Phase II study, naive genotype 1 patients will receive ANA598 or placebo in combination with Pegasys((R)) (peginterferon alfa-2a) and Copegus((R)) (ribavirin, USP) (a current standard of care, or SOC) for 12 weeks at dose levels of 200 mg or 400 mg twice daily (bid), each with a loading dose of 800 mg bid on day one. After week 12, patients will continue to receive SOC. Patients who achieve undetectable levels of virus at weeks 4 and 12 will be randomized to stop all treatment at week 24 or 48. The primary endpoint of the study is the proportion of patients with undetectable virus at week 12 (defined as complete Early Virological Response, or cEVR). Additional endpoints include safety and tolerability as well as the proportion of patients with undetectable virus at week 4 (defined as Rapid Virol
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
2. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
3. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
4. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
5. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
6. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
7. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
8. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
9. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
10. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
11. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  Ameritox, the nation,s leader ... Progressive Medical, Inc. to become part of its ... manage pharmacy costs and improve the clinical outcomes ... leading pharmacy benefit manager in the workers, compensation ... compliance and pain management strategy for several years. ...
(Date:5/23/2013)... Md. , May 23, 2013  BioElectronics Corporation ... consumer medical devices, comments on the FDA panel meeting ... Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was ... MD , USA.  The focus of the meeting ... the panel to focus solely on the application of ...
(Date:5/23/2013)... 2013  CAS Medical Systems, Inc. (NASDAQ: CASM ... monitoring, today announced that Thomas M. Patton ... 2 nd Annual Marcum MicroCap Conference on Thursday, May ... New York City . The presentation is ... 10 room and will be available via a live webcast ...
Breaking Medicine Technology:Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
... Dr. Rolf Badenhoop M.D., a 20-year veteran of the ... sales and marketing consulting firm ZS Associates ... Frankfurt office. "I am excited to work ... better understand and respond to business challenges posed by ...
... VOLC ) today announced its intention to offer, ... amount of convertible senior notes due September 1, 2015 in ... amended (the "Securities Act"). Prior to June 1, 2015, the ... holders will receive up to the principal amount of the ...
Cached Medicine Technology:ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany 2Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 2Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 3Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 4
(Date:5/24/2013)... Scott Ryan Tischler of Tischler Brothers ... 200 lbs. of fat in just over a year. ... brother the importance of exercising. Scott also taught Troy ... these 7 rules of healthy eating and having a ... accomplished. , 1.    Find a distraction when a food craving ...
(Date:5/24/2013)... The leading retail brand Short Dresses has recently ... . Now that is quite unbelievable, especially in view of ... since its origin. The retailer has already revealed its wider ... discount offer will be an added bonanza for the frequent ... announce that Short Dresses is to offer different levels of ...
(Date:5/23/2013)... 2013 Magnatag’s new magnetic 365-Day attendance ... reduces vacation conflicts. A Manufacturing Manager from Augusta GA ... now employees and managers can check the board for ... is important to us and the board makes the ... seem harsh but it has made a difference.” ...
(Date:5/23/2013)... May 24, 2013 Sublime Beauty® ... Cellulite Whisperer line, with a 35% discount ... Sale" includes two proprietary products, the Cellulite ... . , Purchasers receive a report "Getting Control ... Gel has a wonderful grapefruit scent," says Kathy ...
(Date:5/23/2013)... High blood glucose is associated with poor outcomes in ... to control hyperglycemia is a common practice in hospitals. ... benefit and even shows harms associated with the use ... (ACP) Clinical Guidelines Committee in a new evidence-based paper ... Medical Quality . , "Clinicians caring for hospitalized patients ...
Breaking Medicine News(10 mins):Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2
... -- Rice University scientists have captured the first optical ... fruit flies, the researchers confirmed that a technique developed ... of detecting DNA-sized nanotubes inside living fruit flies. , ... they give off fluorescent light in a way that ...
... and sports injury treatment but limitations with current calibration ... that could lead to further injury. New technology developed ... tested by Lothian NHS could greatly improve the accuracy ... , NPL has developed an acoustic ...
... is ,Bold and Visionary, says Global AIDS Alliance Fund, ... Senator John Edwards is announcing a new proposal,for what ... in the US and abroad., To address the ... in resources to reach universal access to prevention and,treatment. ...
... Consumers to ... Beware!, OMAHA, ... Cosmetic Dermatology and Aesthetic,Surgery (ASCDAS), responded to the recent decision by Judge ... Arts to ban the,liposuction treatment, Lipodissolve. "This procedure is still unsafe in ...
... be successful, PITTSBURGH, Sept. 24 For ... be the path to becoming smoke-free. While,there are ... a new national,survey conducted by Nicorette Cinnamon Surge ... an advance plan.(1) In fact, half (49,percent) of ...
... 24 Wyeth (NYSE: WYE ),today kicks off ... and manufacturing facility, honoring the generations of employees,at the ... science,and human health. The 550-acre complex, located in ... employs approximately 3,200 people and is one of,the largest ...
Cached Medicine News:Health News:Scientists get first look at nanotubes inside living animals 2Health News:New acoustic absorber to improve physiotherapy ultrasound machines 2Health News:Edwards' Plan on AIDS Unveiled Today 2Health News:Lipodissolve - Is it Safe??? 2Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 2Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 3Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 4Health News:Wyeth's Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care 2Health News:Wyeth's Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care 3Health News:Wyeth's Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care 4
... The Anti-HCV Low Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by manufacturers and ... Comprehensive data from all major test systems ...
... Panel consists of plasma specimens with reactivity ... antibodies to the Hepatitis C Virus., This ... manufacturers and clinical laboratories to evaluate their ... all major test systems are included for ...
... POPmesh is a ... that can be used ... pelvic floor procedures, including ... prolapse. Supple yet strong, ...
Suspend® Tutoplast® Processed Fascia Lata is your naturally safe and strong choice for pelvic floor reconstruction. Suspend comes from a dense matrix of collagen bundles and transverse fasc...
Medicine Products: